CNBC Daily Open: Trump goes alone in the Iran war — as allies spurn requests to join
U.S. allies seem to be caught between Iranian attacks and criticism from the U.S. president, with focus also on the AI space and the impending Fed rate verdict.
South Korea’s Kospi lead gains in Asia as investors assess Japan trade data, await Fed rate verdict
The Middle East war continues to escalate, keeping investors on edge.
Japan exports beat forecasts with 4.2% growth in February, but shipments to China and U.S. slump
Exports to China, Japan’s largest trading partner, fell 10.9%, while shipments to the U.S dropped 8%.
Nvidia CEO Jensen Huang says OpenClaw is ‘definitely the next ChatGPT’
Nvidia CEO Jensen Huang pointed to a fast-rising project called OpenClaw as a major step forward in how people interact with AI.
Arizona charges Kalshi with criminal misdemeanors, alleging it’s an illegal gambling operation
The Arizona charges are the first criminal charges to have been filed against Kalshi, though the company is embroiled in multiple lawsuits over its predictions platform.
Stocks shake off Tuesday’s oil rise — plus, Amazon debuts even faster delivery
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
The charts are showing stocks are close to breaking out of their ultra-tight range
Todd Gordon walks investors through several market technicals as stocks try to break out of a tight range.
U.S. counterterrorism director Joe Kent resigns over war: ‘Iran posed no imminent threat’
“Iran posed no imminent threat to our nation,” Kent wrote in his letter to President Donald Trump.
European markets need to get their act together, CEO of Norway’s $2 trillion wealth fund says. ‘The winner takes it all’
Nicolai Tangen, CEO of Norges Bank Investment Management, warned Europe is facing a crisis and that “it is time to act.”
Eli Lilly catches a downgrade as HSBC warns of an overhyped obesity drug market
HSBC signals a potential cooling period for the red-hot obesity drug trade.
